Literature DB >> 22889539

Measles virus and associated central nervous system sequelae.

Renee Buchanan1, Daniel J Bonthius.   

Abstract

Worldwide, measles remains one of the most deadly vaccine-preventable diseases. In the United States, enrollment in the public schools requires that each child receives 2 doses of measles-containing vaccine before entry, essentially eliminating this once endemic disease. Recent outbreaks of measles in the United States have been associated with importation of measles virus from other countries and subsequent transmission to intentionally undervaccinated children. The central nervous system complications of measles can occur within days or years of acute infection and are often severe. These include primary measles encephalitis, acute postinfectious measles encephalomyelitis, measles inclusion body encephalitis, and subacute sclerosing panencephalitis. These measles-associated central nervous system diseases differ in their pathogenesis and pathologic effects. However, all involve complex brain-virus-immune system interactions, and all can lead to severe and permanent brain injury. Despite better understanding of the clinical presentations and pathogenesis of these illnesses, effective treatments remain elusive.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889539     DOI: 10.1016/j.spen.2012.02.003

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  37 in total

1.  Case Report: Subacute Sclerosing Panencephalitis Presenting as Acute Encephalitis.

Authors:  Ravindra Kumar Garg; Neeraj Kumar; Imran Rizvi; Amita Jain; Ravi Shekhar Jaipuriar; Praveen Kumar Sharma; Hardeep Singh Malhotra; Danish Nasar Khan; Ravi Uniyal
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

Review 2.  Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.

Authors:  Stephen J Russell; Dusica Babovic-Vuksanovic; Alice Bexon; Roberto Cattaneo; David Dingli; Angela Dispenzieri; David R Deyle; Mark J Federspiel; Adele Fielding; Eva Galanis; Martha Q Lacy; Bradley C Leibovich; Minetta C Liu; Miguel Muñoz-Alía; Tanner C Miest; Julian R Molina; Sabine Mueller; Scott H Okuno; Nandakumar Packiriswamy; Tobias Peikert; Corey Raffel; Frits Van Rhee; Guy Ungerechts; Paul R Young; Yumei Zhou; Kah-Whye Peng
Journal:  Mayo Clin Proc       Date:  2019-06-22       Impact factor: 7.616

Review 3.  Within host RNA virus persistence: mechanisms and consequences.

Authors:  Richard E Randall; Diane E Griffin
Journal:  Curr Opin Virol       Date:  2017-03-17       Impact factor: 7.090

Review 4.  Virus infections in the nervous system.

Authors:  Orkide O Koyuncu; Ian B Hogue; Lynn W Enquist
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

Review 5.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

6.  Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.

Authors:  Sebastien Delpeut; Gary Sisson; Karen M Black; Christopher D Richardson
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

7.  Type I Interferon Receptor Signaling Drives Selective Permissiveness of Astrocytes and Microglia to Measles Virus during Brain Infection.

Authors:  Jeremy Charles Welsch; Benjamin Charvet; Sebastien Dussurgey; Omran Allatif; Noemie Aurine; Branka Horvat; Denis Gerlier; Cyrille Mathieu
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

8.  Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.

Authors:  Cyrille Mathieu; Marion Ferren; Eric Jurgens; Claire Dumont; Ksenia Rybkina; Olivia Harder; Debora Stelitano; Silvia Madeddu; Giuseppina Sanna; Dayna Schwartz; Sudipta Biswas; Diana Hardie; Takao Hashiguchi; Anne Moscona; Branka Horvat; Stefan Niewiesk; Matteo Porotto
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

9.  Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.

Authors:  Jeremy C Welsch; Aparna Talekar; Cyrille Mathieu; Antonello Pessi; Anne Moscona; Branka Horvat; Matteo Porotto
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells.

Authors:  Hila Naaman; Tatiana Rabinski; Avi Yizhak; Solly Mizrahi; Yonat Shemer Avni; Ran Taube; Bracha Rager; Yacov Weinstein; Glenn Rall; Jacob Gopas; Rivka Ofir
Journal:  Cell Reprogram       Date:  2018-02       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.